Stock PLX PROTALIX BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.13 USD -0.88% Intraday chart for Protalix BioTherapeutics, Inc. -8.13% -36.52%
May. 10 Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
May. 10 Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M
Protalix: Q1 Earnings Snapshot
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
Transcript : Protalix BioTherapeutics, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Protalix: Q3 Earnings Snapshot
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLX Stock
  4. News Protalix BioTherapeutics, Inc.
  5. Other languages